| scholarly article | Q13442814 |
| P2093 | author name string | Anand R | |
| Lindstrom J | |||
| Peng X | |||
| Whiting PJ | |||
| Gerzanich V | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 523-530 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover | |
| P478 | volume | 46 |
| Q34109947 | 86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization |
| Q41753677 | A critical period for nicotine-induced disruption of synaptic development in rat auditory cortex. |
| Q37707730 | Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors |
| Q35978097 | Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors. |
| Q33240001 | Airway-related vagal preganglionic neurons express multiple nicotinic acetylcholine receptor subunits |
| Q37012983 | Alpha4 containing nicotinic receptors are positioned to mediate postsynaptic effects on 5-HT neurons in the rat dorsal raphe nucleus. |
| Q44699098 | Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. |
| Q30488629 | Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning |
| Q43691431 | Brain metabolic effects of acute nicotine |
| Q42173324 | Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation |
| Q37247103 | Cellular events in nicotine addiction |
| Q40687661 | Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. |
| Q40821290 | Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. |
| Q36465049 | Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism |
| Q37454529 | Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. |
| Q42851032 | Cigarettes and addiction |
| Q30396291 | Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking |
| Q58551486 | Craving espresso: the dialetics in classifying caffeine as an abuse drug |
| Q74023744 | Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors |
| Q37148158 | Cyclic AMP-dependent protein kinase A and protein kinase C phosphorylate alpha4beta2 nicotinic receptor subunits at distinct stages of receptor formation and maturation |
| Q35209559 | Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD |
| Q35073748 | Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure |
| Q44418971 | Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. |
| Q28345770 | Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells |
| Q42728333 | Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro |
| Q43263931 | Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells |
| Q35209455 | Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons |
| Q35562759 | Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors |
| Q42614063 | Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit. |
| Q36274171 | Exposure to nicotine and sensitization of nicotine-induced behaviors |
| Q37398823 | Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. |
| Q48439102 | Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. |
| Q36779488 | Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors |
| Q34715683 | Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain |
| Q35951334 | Increased nicotinic receptor desensitization in hypoglossal motor neurons following chronic developmental nicotine exposure |
| Q48954592 | Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. |
| Q27010347 | Inside-out neuropharmacology of nicotinic drugs |
| Q42707905 | Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine |
| Q35952287 | Introduced Amino Terminal Epitopes Can Reduce Surface Expression of Neuronal Nicotinic Receptors |
| Q42565570 | Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity |
| Q37728109 | Kinetics of desensitization and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells |
| Q43662839 | Long-lasting enhancement of glutamatergic synaptic transmission by acetylcholine contrasts with response adaptation after exposure to low-level nicotine. |
| Q40354072 | Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells |
| Q27658065 | Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity |
| Q24647069 | Mammalian nicotinic acetylcholine receptors: from structure to function |
| Q37018610 | Mechanism-based medication development for the treatment of nicotine dependence. |
| Q47117295 | MicroRNA Regulation of nAChR Expression and Nicotine-Dependent Behavior in C. elegans |
| Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
| Q28254128 | Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors |
| Q35185264 | Naturally-expressed nicotinic acetylcholine receptor subtypes |
| Q37196810 | Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q38477044 | Neuronal nicotinic receptors in sleep-related epilepsy: studies in integrative biology |
| Q37241631 | Nicotine activates and up-regulates nicotinic acetylcholine receptors in bronchial epithelial cells |
| Q30560877 | Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors. |
| Q37413060 | Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. |
| Q34439566 | Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning |
| Q34211873 | Nicotine-induced up regulation of α4β2 neuronal nicotinic receptors is mediated by the protein kinase c-dependent phosphorylation of α4 subunits |
| Q35777580 | Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms |
| Q37525085 | Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction |
| Q41659796 | Nicotinic acetylcholine receptors in health and disease |
| Q26782271 | Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use |
| Q35541262 | Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction |
| Q30490604 | Pharmacodynamics of memantine: an update |
| Q38193225 | Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease. |
| Q35996739 | Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response. |
| Q48925282 | Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes |
| Q35041679 | Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors |
| Q36949979 | Potential therapeutic uses of mecamylamine and its stereoisomers |
| Q42516825 | Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice |
| Q33954007 | Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors |
| Q34668336 | RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation |
| Q37075854 | RIC-3: a nicotinic acetylcholine receptor chaperone |
| Q36105397 | Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures |
| Q49151499 | Regulation of the sensitivity of acetylcholine receptors to nicotine in rat habenula neurons |
| Q49029100 | Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation |
| Q58575281 | Serine residues in the α4 nicotinic acetylcholine receptor subunit regulate surface α4β2* receptor expression and clustering |
| Q40587312 | Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis |
| Q52274270 | The biological, social and clinical bases of drug addiction: commentary and debate. |
| Q28188380 | The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications |
| Q33887372 | The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited |
| Q46369907 | Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response |
| Q44023822 | Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. |
| Q48915839 | Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine |
| Q37195457 | Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice |
| Q33551855 | beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking |
| Q34546087 | miRNAome analysis of the mammalian neuronal nicotinic acetylcholine receptor gene family |
Search more.